Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Gene-regulatory axes of diffuse large B-cell lymphoma subtypes

Julius Enssle, Boya Wang, George Wright, Xin Yu, James Phelan, Yandan Yang, Arthur Shaffer, Da Wei Huang, Zana Coulibaly, Michael Kelly, Bao Tran, Stefania Pittaluga, Mark Roschewski, Wyndham Wilson, Thomas Oellerich, Giorgio Inghirami, Louis Staudt

Blood (2025) 146 (Supplement 1): 5313.

https://doi.org/10.1182/blood-2025-5313

Published: 2025

Journal Articles

The role of RhoA in diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5308.

https://doi.org/10.1182/blood-2025-5308

Published: 2025

Journal Articles

JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells.

Jeremy Deuel, Andrejs Makarovs, Sheidasadat Goosheh, George Winder, Hisham Mohammed, Jason Carroll, Mike Chapman, Chiraag Kapadia, Peter Campbell, Jyoti Nangalia, Elisa Laurenti, Constanze Schneider, Thomas Oellerich, Anthony Green, Stephen Loughran

Blood (2025) 146 (Supplement 1): 3149.

https://doi.org/10.1182/blood-2025-3149

Published: 2025

Journal Articles

Impact of IKZFplus status and ABL1 kinase domain mutations in patients with newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia receiving imatinib and chemotherapy followed by allogeneic SCT within GMALL07/03

Blood (2025) 146 (Supplement 1): 3373.

https://doi.org/10.1182/blood-2025-3373

Published: 2025

Journal Articles

First promising results in younger adult patients (<65 yrs) with newly diagnosed ph/BCR::ABL positive ALL treated within the randomized GMALL evolve trial

Fabian Lang, Heike Pfeifer, Boris Böll, Knut Wendelin, Andreas Viardot, Andreas Burchert, Georg-Nikolaus Franke, Sonja Martin, Stefan Schwartz, Joerg Westermann, Klaus Wethmar, Monika Brüggemann, Lena Reiser, Thomas Oellerich, Hubert Serve, Nicola Gökbuget

Blood (2025) 146 (Supplement 1): 3342.

https://doi.org/10.1182/blood-2025-3342

Published: 2025

Journal Articles

Proteogenomic analysis of NPM1-mutated AML reveals clinical heterogeneity related to differentiation states and mitochondrial metabolism

Sebastian Wolf, Josefine Jakob, Björn Häupl, Annika Meid, Daniela Späth, Felicitas R Thol, Hubert Serve, Konstanze Döhner, Hartmut Döhner, Thomas Oellerich

Blood (2025) 146 (Supplement 1): 660.

https://doi.org/10.1182/blood-2025-660

Published: 2025

Journal Articles

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

Thomas Oellerich, Rebecca Wurm-Kuczera, Shashwat Sahay, Meng Wang, Salaheddine Ali, Nazli Serin, Khouloud Kouidri, Donika Tahiri, Sebastian Scheich, Uta Brunnberg, David Winkler, Samixa Pudasaini, Zoi Saxonis, Atef Abdelhafez, Tatiana Borodina, Ulrike Krueger, David Böckle, Corinna Leng, Joseph Kauer, Isabelle Krämer, Konstantinos Christofyllakis, Marcel Teichert, Niklas Gebauer, Ulf Schnetzke, Thomas Weber, Lukas Frenzel, Anna-Carina Hund, Evgenii Shumilov, Thomas Melchardt, Florian Eisele, Mirjeta Berisha, Jakob Rudzki, Christian Scholz, Martin Schmidt-Hieber, Dimitrios Mougiakakos, Johannes Duell, Gerald Wulf, Christian Schmidt, Georg Lenz, Bastian von Tresckow, Hans Christian Reinhardt, Richard Greil, Lorenz Thurner, Peter Dreger, Martin Dreyling, Christiane Pott, Martina Rudelius, Oliver Weigert, Phillipp Strubel, Roland Eils, Antonia Busse, Ulrich Keller, Naveed Ishaque, Björn Chapuy

Blood (2025) 146 (Supplement 1): 3688.

https://doi.org/10.1182/blood-2025-3688

Published: 2025

Journal Articles

Outcome of adult B-precursor acute lymphoblastic leukemia (ALL) treated with blinatumomab in addition to chemotherapy independent of MRD: First results from the national GMALL registry

Blood (2025) 146 (Supplement 1): 5124.

https://doi.org/10.1182/blood-2025-5124

Published: 2025

Journal Articles

Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia

Constanze Schneider, Gabriela Alexe, Ashleigh Meyer, Lucy A Merickel, Allen T Basanthakumar, Audrey Taillon, Silvi Salhotra, Yara Rodriguez, Björn Häupl, David E. Root, Thomas Oellerich, Kimberly Stegmaier

Blood (2024) 144 (Supplement 1): 205.

https://doi.org/10.1182/blood-2024-206333

Published: 2024

Journal Articles

The Transcriptional Activators p300/Crebbp Are Context-Dependent Functional Repressors of Interferon Genes, Offering Therapeutic Promise in AML

Markus Meyerhöfer, Viral Shah, Aarón Gallego-Crespo, Malte Andreas Behrendt, Yawen Zhou, Maria Saura-Pañella, Björn Häupl, Thomas Kindler, Matthias Theobald, Falk Butter, George S Vassiliou, Michael Kühn, Brian J P Huntly, Thomas Oellerich, Daniel Sasca

Blood (2024) 144 (Supplement 1): 152.

https://doi.org/10.1182/blood-2024-194781

Published: 2024

Journal Articles

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Blood (2024) 144 (Supplement 1): 229.

https://doi.org/10.1182/blood-2024-204606

Published: 2024

Journal Articles

Genetic Subclones Reveal Phenotypic Heterogeneity in Diffuse Large B-Cell Lymphoma

Boya Wang, George W. Wright, Julius C. Enssle, Yandan Yang, Da Wei Huang, Xin Yu, Arvin E Ruiz, James D. Phelan, Arthur L Shaffer, III, Thomas Oellerich, Giorgio Inghirami, Louis M. Staudt

Blood (2024) 144 (Supplement 1): 451.

https://doi.org/10.1182/blood-2024-204201

Published: 2024

Journal Articles

Characterizing the Microbiome-Immune Axis in Hematopoietic Stem Cell Recipients

Sabrina A. Becker, Julius C. Enssle, Anne C. Wilke, Sylvia Pfundt, Nico Zeltner, Ana Jankovic, Sebastian Wolf, Thomas A. Wichelhaus, Volkard A. J. Kempf, Maria J. G. T. Vehreschild, Hubert Serve, Thomas Oellerich, Björn Steffen, Sebastian Scheich

Blood (2024) 144 (Supplement 1): 2022.

https://doi.org/10.1182/blood-2024-207279

Published: 2024

Journal Articles

Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 6494.

https://doi.org/10.1182/blood-2024-200002

Published: 2024

Journal Articles

Incidence, Risk Factors, and Outcomes of Candida Bloodstream Infections in Hematological and Oncological Patients

Sebastian Wolf, Sarah Weber, Aaron Janetta, Friederike Klein, Julius C. Enssle, Michael Hogardt, Volkard A. J. Kempf, Johanna Kessel, Maria J. G. T. Vehreschild, Björn Steffen, Thomas Oellerich, Hubert Serve, Sebastian Scheich

Blood (2024) 144 (Supplement 1): 2866.

https://doi.org/10.1182/blood-2024-205960

Published: 2024

Journal Articles

Hematopoietic Differentiation from Single Codon Perspective

Marius Külp, Adrien Jolly, Tessa Schmachtel, Björn Häupl, Thomas Oellerich, Halvard Bonig, Michael A. Rieger

Blood (2024) 144 (Supplement 1): 433.

https://doi.org/10.1182/blood-2024-209604

Published: 2024

Journal Articles

Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

Blood (2024) 143 (22): 2284–2299.

https://doi.org/10.1182/blood.2023021640

Published: 2024

Includes: Supplemental data

Journal Articles

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Blood (2023) 142 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2023-174384

Published: 2023

Journal Articles

Immune Responses after One Versus Two Influenza A/B Vaccinations in Patients with Multiple Myeloma

Julius Enssle, Tonio Brinkschmidt, Ralf Dürrwald, Sebastian Wolf, David Zurmeyer, Björn Steffen, Evelyn Ullrich, Hubert Serve, Thomas Oellerich, Ivana von Metzler

Blood (2023) 142 (Supplement 1): 4737.

https://doi.org/10.1182/blood-2023-180096

Published: 2023

Journal Articles

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Blood (2023) 142 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2023-174325

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Gene-regulatory axes of diffuse large B-cell lymphoma subtypes

The role of RhoA in diffuse large B-cell lymphoma

JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells.

Impact of IKZFplus status and ABL1 kinase domain mutations in patients with newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia receiving imatinib and chemotherapy followed by allogeneic SCT within GMALL07/03

First promising results in younger adult patients (<65 yrs) with newly diagnosed ph/BCR::ABL positive ALL treated within the randomized GMALL evolve trial

Proteogenomic analysis of NPM1-mutated AML reveals clinical heterogeneity related to differentiation states and mitochondrial metabolism

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

Outcome of adult B-precursor acute lymphoblastic leukemia (ALL) treated with blinatumomab in addition to chemotherapy independent of MRD: First results from the national GMALL registry

Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia

The Transcriptional Activators p300/Crebbp Are Context-Dependent Functional Repressors of Interferon Genes, Offering Therapeutic Promise in AML

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Genetic Subclones Reveal Phenotypic Heterogeneity in Diffuse Large B-Cell Lymphoma

Characterizing the Microbiome-Immune Axis in Hematopoietic Stem Cell Recipients

Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma

Incidence, Risk Factors, and Outcomes of Candida Bloodstream Infections in Hematological and Oncological Patients

Hematopoietic Differentiation from Single Codon Perspective

Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Immune Responses after One Versus Two Influenza A/B Vaccinations in Patients with Multiple Myeloma

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only